Migrant’s access to preventive health services in five EU countries by Rosano, Aldo et al.
RESEARCH ARTICLE Open Access
Migrant’s access to preventive health
services in five EU countries
Aldo Rosano1,2, Marie Dauvrin3, Sandra C. Buttigieg4, Elena Ronda5, Jean Tafforeau6 and Sonia Dias7*
Abstract
Background: Preventive health services (PHSs) form part of primary healthcare with the aim of screening to
prevent disease. Migrants show significant differences in lifestyle, health beliefs and risk factors compared with the
native populations. This can have a significant impact on migrants’ access to health systems and participation in
prevention programmes. Even in countries with widely accessible healthcare systems, migrants’ access to PHSs may
be difficult. The aim of the study was to compare access to preventive health services between migrants and native
populations in five European Union (EU) countries.
Methods: Information from Health Interview Surveys of Belgium, Italy, Malta, Portugal and Spain were used to
analyse access to mammography, Pap smear tests, colorectal cancer screening and flu vaccination among migrants.
The comparative risk of not accessing PHSs was calculated using a mixed-effects multilevel model, adjusting for
potential confounding factors (sex, education and the presence of disability). Migrant status was defined according
to citizenship, with a distinction made between EU and non-EU countries.
Results: Migrants, in particular those from non-EU countries, were found to have poorer access to PHSs. The overall
risk of not reporting a screening test or a flu vaccination ranged from a minimum of 1.8 times (colorectal cancer
screening), to a high of 4.4 times (flu vaccination) for migrants. The comparison among the five EU countries
included in the study showed similarities, with particularly limited access recorded in Italy and in Belgium for non-
EU migrants.
Conclusions: The findings of this study are in accordance with evidence from the scientific literature. Poor
organization of health services, in Italy, and lack of targeted health policies in Belgium may explain these findings.
PHSs should be responsive to patient diversity, probably more so than other health services. There is a need for
diversity-oriented, migrant-sensitive prevention. Policies oriented to removing impediments to migrants’ access to
preventive interventions are crucial, to encourage more positive action for those facing the risk of intersectional
discrimination.
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Background
Preventive health services (PHSs) form part of primary
healthcare with the aim of screening for and preventing
diseases. The goal of a PHS is to reduce morbidity and
mortality through prevention and early detection of pre-
ventable diseases [1]. However, barriers to access to pre-
ventive health services can be higher than to other
health services; this may even be more problematic for
some vulnerable groups such as migrants [2]. Migrants
show significant differences in lifestyle, health beliefs
and risk factors compared with the national populations
that may prevent them from accessing health services
and participating in prevention programs [3]. Even in
countries with widely accessible healthcare systems, mi-
grants’ access to PHSs may be problematic.
Migrants encounter legal, financial, cultural and geo-
graphical barriers to health care access including absence
of health insurance coverage, linguistic and cultural prob-
lems, and lack of access to information (affecting the poorly
educated and those with a poor health literacy). Other
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factors overlie all of these barriers, such as the inability to
afford the direct financial costs of care (affecting low-
income groups), lack of mobility (affecting disabled and
elderly persons), as well as gender issues [4]. As a conse-
quence, being a migrant may include any of these barriers.
In this study, we analysed the following PHSs: screening
for breast cancer, cervical cancer and colorectal cancer
and flu vaccination. The choice was conditional on the
availability of relevant information in the selected data
sources, the national Health Interview Surveys (NHIS).
Secondary cancer prevention programs are particularly
important for migrants because they often underuse pre-
ventive care, fail to attend follow-up consultations, and
lack of cancer awareness. Migrants are more likely to re-
ceive a diagnosis of cancer at an advanced stage [5].
Limited access to screenings is one possible reason for
this. This problem tends to decrease as the length of stay
of migrants in the host country increases [2].
Breast cancer is the most commonly diagnosed cancer
among women worldwide [6]. Breast cancer screening is
performed through mammography and breast self-
examination and should be started between the ages of 40
and 50 (or earlier depending on family history). Among mi-
grants living in the United States of America (USA), large
disparities exist for secondary prevention, as migrants tend
to adopt a rather passive attitude toward screening [2].
Cervical cancer is the second most common cancer in
women from developing countries [6]. In many coun-
tries, screening uptake in migrant women is far below
target and significantly lower than for the national popu-
lation. Reasons for non-participation in cervical cancer
screening are mostly related to language problems and
dissatisfaction with health care professionals. Religion
may also play an important role, women may be reluc-
tant to be examined by male doctors [2].
Colorectal cancer is much more common in developed
countries and is associated with dietary habits and environ-
mental risk factors. It is recommended that screening starts
at around the age of 50 using faecal occult blood tests and
endoscopic exams. Colorectal cancer is the second most
common cancer in Europe, causing over 200,000 deaths
per year [7]. Population-based colorectal cancer screening
has proven to be effective in reducing colorectal cancer in-
cidence and mortality. [8] In the USA, colorectal screening
tends to be lower for migrants than for the national
American population. However, screening patterns con-
verge towards that of the national population as the length
of stay in the country increases [2].
Influenza is a vaccine-preventable disease that infects
around 15% of European population each year. Older
people, young children and those with chronic condi-
tions suffer the most although everyone is at risk of de-
veloping serious complications that may result in death
[9]. In the USA, influenza vaccination coverage among
most racial/ethnic groups has increased in recent years,
but substantial racial and ethnic disparities remain in
most age groups [10]. Evidence from European countries
is limited to a few countries [11, 12], with migrants hav-
ing a lower probability of receiving the influenza vaccine
compared with national population.
As highlighted above, studies on the access of migrants
to PHSs are more common in the USA. Conversely, few
studies in Europe have investigated migrants’ access to
PHSs. The available evidence shows that European
Union (EU) countries’ migrants have lower rates of pre-
ventive service utilization than national populations, des-
pite the narrowing gap in recent years for some of these
services, such as breast and cervical cancer screening
[13, 14]. According to the European Charter of Funda-
mental Rights [15] “Everyone has the right of access to
preventive health care” - but - “under the conditions
established by national laws and practices”. Meeting the
health needs of migrants depends on the health system
of the host country. Despite the EU’s declared intention
to harmonize their entitlements, there are still significant
differences also for documented migrants. Although the
law may grant migrants certain entitlements to healthcare
coverage, administrative procedures or cultural barriers
often prevent them from exercising these rights [16].
The data available from some EU countries suggest the
presence of inequalities in health care use, since migrants
tends to have a greater reliance on emergency services, be-
cause of inadequate access to other services, such as pri-
mary and/or specialist care [17]. Particularly worrisome are
the low utilization rates of antenatal and paediatric care,
and preventive services [18]. High quality studies based on
comparable data and adjusting for selected factors are
needed to make valid decisions on how to secure equity in
the access of migrant to health services. [17]. This study
aimed at comparing access to preventive health services be-
tween migrants and national populations, while considering
some factors that may confound or interact with the rela-
tionship between access to PHSs and migrant status.
Methods
This study was a retrospective period prevalence study,
based on secondary data from the national Health Inter-
view Surveys (HISs) of Belgium, Italy, Malta, Portugal and
Spain. Data were respectively collected in 2008 for Malta,
2011 for Spain, 2012–13 for Italy, 2013 for Belgium and
2014 for Portugal. The National NHIS are cross-sectional
survey intended to provide nationally representative esti-
mates on a wide range of health status and utilization
measures among the noninstitutionalized population.
They are conducted in many European countries with dif-
ferent periodicity with a large sample size and allow to
provide reliable statistics on the principal health domains.
Data from NHIS are currently used to calculate various
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European Core Health Indicators (ECHI) consisting in a
comparable health information and knowledge system for
monitoring health at EU level [19].
Data source and variables of interest
We collected individual information from HISs regard-
ing access to mammography, Pap smear tests, colorectal
cancer screening and flu vaccination.
Four indicators of PHS access were considered, ac-
cording to the European Core Health Indicators’ defini-
tions [20]:
(1) Percentage of women (aged 50–69) reporting a
mammography in the past 2 years;
(2) Percentage of women (aged 20–69) reporting a Pap
smear test in the past 3 years;
(3) Percentage of persons (aged 50–74) reporting a
colorectal cancer screening in the past 2 years;
(4) Percentage of persons aged 65 and over reporting a
vaccination against flu in the past 12 months.
Appendix 1 presents additional information about the
availability of other items on screening programs in na-
tional HIS and the existence of a screening program.
Demographic characteristics retrieved from the HISs
were citizenship, age and sex of participants. Migrant
status was defined according to citizenship as the mi-
grants included in the national HIS are migrants with a
legal permit of residence in the host country. Migrants
were distinguished between migrants originating from a
European country member of the EU and migrants of
non-European countries.
Additionally, two variables that may influence the rela-
tionship between migrant status and access to PHSs
were retrieved from the HISs database: level of educa-
tion and the presence of disability. Education was classi-
fied into three levels: no education/primary, secondary
and higher education. The presence of disability was
coded as a dichotomous variable according to the re-
ported long-term limitation, irrespective of its severity.
Analysis
Analysis was computed for nationals, migrants with
European citizenship (EU) and migrants with a non-EU
citizenship. In order to compare the percentage of mi-
grants accessing PHSs with that of nationals, odds ratios
(ORs) were estimated using logistic regression models ad-
justed for potential confounders (sex, presence of disabil-
ity, education), using nationals as a reference. Country-
specific ORs were calculated, as well as overall risks.
To consider the country level factors, a mixed-effects
multilevel model was used to estimate the overall ORs.
The multilevel regression considered that the individual
probability was also statistically dependent on the country
of residence [21]. The Intraclass Correlation Coefficient
(ICC) was used to test the need to use multilevel models.
The ICC varies from +1 when group risks differed, but
within any group there is no variation, to −1/(n-1) when
group means are equal but the within-group variation is
large [22]. Random effects parameters were used to explain
the correlation and variation of the latent mean values
around the population average values. The ICC was large
enough to account for the clustering (country) effect when
analysing mammography (ICC = 0.15; 95% C.I.: 0.05–0.39)
and colorectal cancer screening (ICC = 0.19; 95% C.I.:
0.06–0.46). Conversely the ICC was only slightly significant
when analysing Pap smear testing (ICC = 0.01; 95% C.I.:
0.00–0.34) and vaccination against flu (ICC = 0.04; 95%
C.I.: 0.01–0.13). Therefore, multilevel models were only
used for analysing mammography and colorectal cancer
screening whereas one-level logistic regression models
were used for analysing Pap smear testing and flu vaccin-
ation, since the observations within clusters (countries) are
no more similar than observations from different clusters.
Based on the HIS surveys, we also calculated the percent-
age of women invited by national or regional screening pro-
grammes, by citizenship, to assess the capacity of screening
programmes to attract migrant women. The STATA soft-
ware, release 13, was used to analyse the data [23].
Results
Participants
Table 1 presents the sociodemographic characteristics of
the subjects included in the analysis. A total of 151,311
subjects were analysed: 5480 from Belgium, 102,953
from Italy, 3668 from Malta, 18,203 from Portugal and
21,007 from Spain. The sample included 46% of men,
54% of women, 6% of migrants and 94% of nationals.
Access to PHS
Tables 2, 3, 4 and 5 presents the percentage of subjects
reporting a screening test or a flu vaccination according
to the type of test and the country of residence. Exclud-
ing Malta, in all countries, access to Pap smear tests,
colorectal cancer screening and flu vaccination was
lower for migrants from non-EU countries than for na-
tionals and EU migrants. Access to mammography was
therefore the lowest for those from EU countries when
compared to non EU migrants and nationals.
Table 6 presents the percentage of women attending
organized national or regional screening programmes,
estimated from the data of national HISs considered in
this study. Self-reported attendance for such screening
was the highest in Italy and Spain, and the lowest in
Belgium and Malta. The proportion of migrant women
attending screening programmes is 46% lower than na-
tionals for breast cancer screening but only 5% lower for
Pap smear tests. In Italy and Belgium, this proportion
was higher among migrant women than nationals.
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Risks of not reporting access to PHSs
Tables 7, 8, 9 and 10 presents the risks o migrants, in terms
of odds ratios, of self-reported lack of access to PHSs as
well as the risks associated with selected variables of influ-
ence. The overall risk of not reporting PHSs use was the
lowest for colorectal cancer screening and the highest for
flu vaccination for all migrants. The overall risks of not at-
tending the PHSs were the highest in Italy and lowest in
Belgium (excluding Malta), all PHSs compounded.
When comparing EU migrants and non-EU migrants,
higher risks were found for non-EU migrants, except in the
case of mammography. The disparity was particularly no-
ticeable in Belgium, where access to all analysed screening
tests was lower among non-EU migrants than EU migrants.
The presence of disability did not have a significant in-
fluence and was later removed in the final models. The
level of education (using lower education as a reference)
appeared, conversely, to be a significant factor: the risk
of not reporting a mammography was reduced by 30%
for persons with the highest educational level, as well as
that of not reporting Pap smear testing. The risk of not
reporting a colorectal cancer screening was the lowest
for those with higher education by 10%, while that of
not reporting vaccination against flu was reduced by
35% among persons with a high level of education. Fi-
nally, gender was also a significant factor both in colo-
rectal cancer screening and for flu vaccination. There
was a higher risk of not reporting colorectal cancer
screening among women (+11%) and a lower risk of not
reporting the flu vaccination among women (−14%).
Discussion
Access is considered equitable if it does not depend on, e.g.,
education, income, migrant status or ethnicity. Comparing
utilization between different population groups in order to
investigate inequity in access requires adequate indicators
on the health care needs. To measure directly the access it
is essential to know the population needing for care, which
is quite difficult to detect. However, when comparing
utilization of preventive services, such as population-based
screening for breast cancer, the need is simply defined on
the basis of age and gender (every woman in a certain age
group is considered to be in need). [24]
Early detection during screening programs for breast,
cervical, and colorectal cancer is a key factor for better
survival in high-risk groups. Migrants were found to
have poorer access to PHSs than nationals, this was par-
ticularly true for those from non-EU countries. The
Table 2 Proportion of Pap smear test in the past 3 years (n = 17,724)
Citizenship Total
Nationals EU migrants Non- EU migrants
N (%) CI 95% N (%) CI 95% N (%) CI 95%
Country
Belgium 677 (70.4) 67.5–73.3 63 (69.9) 60.4–79.3 51 (46.9) 37.5–56.3 69.5
Italy 9984 (66.8) 66.1–67.6 352 (55.7) 51.8–59.5 727 (48.5) 46.0–51.1 65.8
Malta 585 (57.9) 54.8–60.9 7 (70.8) 42.5–99.2 8 (55.6) 29.9–81.2 58.1
Portugal 2593 (63.2) 61.7–64.7 39 (50.6) 39.5–61.8 46 (63.8) 52.7–74.9 63.1
Spain 2287 (68.5) 66.9–70.1 97 (58.2) 50.7–65.7 208 (63.1) 57.9–68.3 67.8
Total 16,126 (66.5) 65.9–67.1 558 (58.3) 55.2–61.4 1040 (53.1) 50.9–55.3 65.7
Data were collected for women aged 20–69
Table 3 Proportion of colorectal cancer screening in the past 2 years (n = 49,259)
Citizenship Total
Nationals EU migrants Non- EU migrants
N (%) CI 95% N (%) CI 95% N (%) CI 95%
Country
Belgium 1789 (16.5) 15.8–17.2 115 (20.7) 17.3–24.1 35 (7.9) 5.4–10.4 16.6
Italy 32,702 (12.6) 12.4–12.7 313 (7.9) 7.1–8.8 683 (6.3) 5.9–6.8 12.4
Malta 1264 (2.2) 2.12–2.4 28 (12.5) 8.17–16.8 1 (50.0) 0.0–100.0 2.6
Portugal 5258 (27.4) 26.7–28.0 70 (17.6) 13.9–21.4 39 (18.8) 13.4–24.1 27.2
Spain 6667 (6.3) 6.2–6.5 135 (2.9) 2.4–3.4 160 (8.6) 7.3–9.8 6.3
Total 47,680 (13.6) 13.5–13.7 661 (10.8) 10–11.6 918 (7.5) 7.0–7.9 13.5
Data are collected for persons aged 50–74
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comparison among the five EU countries included in the
study showed similarities, with slightly poorer access in
Italy and with the exception of Malta. Malta showed bet-
ter access for migrants to PHSs both for female screen-
ings (mammography and Pap smear tests) and for flu
vaccination when compared to nationals. Even if the evi-
dence is not strong because of the limited sample size,
such a phenomenon is true for any type of screening. A
possible explanation is the Maltese public health policy
targeting the most vulnerable groups first for screening
programmes and vaccination, in order to reduce the bur-
den of access to hospital care [25].
Our findings are in accordance with to previous stud-
ies: Visser reported that women born in non-western
European countries attend breast cancer screening less
frequently than women born in the Netherlands, and
register a lower detection rate, which explains a passive
attitude to low attendance [26]; previous studies from
the United Kingdom, the Netherlands and Spain showed
that uptake for cervical screening was lower among mi-
grants compared with non-migrants [27, 28]; similarly,
Anson [29] reported that access to preventive services,
such as vaccination for tetanus, influenza and rubella, as
well as screening for early detection of breast and cer-
vical cancer was better among native Belgians compared
with immigrants from Morocco and Turkey even after
controlling for socio-demographic characteristics.
In Denmark and Sweden, lower participation rate was
recorded for migrant women in mammography screen-
ing compared with native-born women. Possible reasons
for this are the factors influencing the screening behav-
iour, namely a lack of knowledge, bureaucratic barriers
and cultural issues [30, 31].
In countries with a Beveridge-like health system, such
as Italy, Spain and Malta, it should be easier for mi-
grants to access PHSs compared with health systems
based on an insurance system, such as in Belgium, or
with mixed systems, as in Portugal. Likewise, Francovich
and colleagues [14] showed that in Italy migrant access
to mammography was as low as 20% compared with na-
tive Italians, while the uptake of Pap smear tests was re-
duced by 35%. Women coming from South America
recorded better access to mammography and Pap smear
tests, while those from Africa recorded the worst access.
For both screenings, a longer length of stay in Italy was
positively correlated with better access to PHSs. This
Table 4 Proportion of flu vaccination in the past 12 months (n = 34,435)
Citizenship Total
Nationals EU migrants Non- EU migrants
N (%) CI 95% N (%) CI 95% N (%) CI 95% %
Country
Belgium 457 (51.4) 48.1–54.7 43 (35.8) 27.2–44.4 10 (50.0) 28.1–71.9 50.4
Italy 26,568 (36.0) 35.7–36.4 352 (11.8) 10.6–12.9 1074 (10.1) 9.5–10.6 35.1
Malta 275 (56.6) 52.2–61.0 6 (64.7) 33.9–95.5 0 56.8
Portugal 3139 (44.1) 42.9–45.2 40 (23.1) 16.8–29.3 4 (100.0) 100.0–100.0 43.9
Spain 2410 (58.4) 56.9–59.9 30 (46.4) 34.3–58.6 27 (43.8) 31.4–56.1 58.2
Total 32,849 (39.7) 39.4–40.1 471 (20.3) 18.7–21.9 1115 (11.9) 11.3–12.6 38.9
Data are collected for persons aged 65 and over
Table 5 Proportion of mammography attendance in the past 2 years (n = 7837)
Citizenship Total
Nationals EU migrants Non- EU migrants
N (%) CI 95% N (%) CI 95% N (%) CI 95%
Country
Belgium 268 (73.4) 68.8–77.9 16 (73.3) 54.8–91.9 5 (66.7) 32.9–100 73.3
Italy 5402 (63.7) 62.7–64.7 127 (38.0) 32.8–43.3 202 (43.9) 39.4–48.4 62.9
Malta 404 (30.9) 28.4–33.4 5 (61.5) 28.1–95.0 31.6
Portugal 641 (80.9) 78.1–83.6 17 (52.8) 35.5–70.0 10 (61.5) 37.9–85.2 80.4
Spain 668 (79.1) 76.3–81.8 41 (45.3) 35.1–55.6 31 (65.6) 52.0–79.1 77.9
Total 7383 (67.9) 67.0–68.8 206 (47.0) 42.4–51.7 248 (49.5) 45.1–53.9 67.2
Data are collected for women aged 50–69
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supports the hypothesis that the process of integration
and/or regularization of migrants, as well as specific in-
terventions for the involvement of foreign women,
would facilitate their access to PHSs.
The percentages of women invited by national or re-
gional screening programmes calculated in this study are
in line with those from other official statistical sources
[32]. The proportion of migrant women participating in
organized screening programs was lower than that of na-
tionals, especially for breast cancer screening. Overall, the
proportion of women participating in the programmes for
cervical cancer screening is very low in Belgium and in
Malta. Nevertheless, the proportion of women having a
Pap smear test is quite high both for nationals and mi-
grants. This illustrates the serious problems of the screen-
ing programs in those countries, partially mitigated by
opportunistic screening. In all the countries included in
this study, the percentage of women invited by cervical
cancer screening programs is similar for natives and mi-
grants, with slightly higher numbers among migrants in
Italy and Belgium. In those countries, the screening pro-
grams are able to reduce the gap in access to cervical can-
cer prevention for migrant women.
The proportion of interviewed subjects reporting a colo-
rectal cancer screening was very low (1 out of 7). Only in
Italy, there was a significantly lower proportion among mi-
grants, in particular among those from countries outside
the EU. This appears to be due to a general lack of know-
ledge about colorectal cancer, which was more pronounced
among some minority groups [33]. Cultural factors may
also play a role, e g. fatalism (the perception of everything
as being ordained by fate) was found to be associated with
a lower uptake of colorectal cancer screening [34]. Our
study showed a reduced level of vaccination against flu
among migrants, particularly in Italy. This difference was
more apparent among non- EU citizens and this result is in
line with previous findings from Spain [35] and Italy [36].
Access to PHS for migrants’ access is affected differ-
ently at different levels of the health system. Several is-
sues are concerned with equity in health care access,
such as entitlements, health policies, structure and
organization of services, and the attitude of health pro-
fessionals towards migrants [24].
The legal framework of entitlement in Belgium, Italy,
Portugal and Spain is among the most favourable to
everyone living on their territories, including docu-
mented and undocumented migrants, among the EU
countries. Health policies may facilitate the access of mi-
grants to health services by defining entitlements by law,
Table 6 Percentage of women invited by national or regional
screening programmes in 5 European countries, by citizenship
and by country
Screening programs
Mammography Pap smear test
Nationals (%) Migrants (%) Nationals (%) Migrants (%)
Country
Belgium 21.9 9.3 3.0 3.7
Italy 37.7 29.6 34.2 37.7
Malta 3.2 0.0 1.1 0.0
Spain 50.8 29.3 18.5 11.6
Total 38.8 26.6 29.4 28.1
Table 7 Odds Ratio of not reporting a mammography in the past 2 years
Citizenship
Migrants EU Migrants Non-EU Migrants
OR CI 95% OR CI 95% OR CI 95%
Migrant status
National (ref)
Migrant status 2.46 2.14–2.89 2.68 2.18–3.29 2.36 1.97–2.82
Educational level
No education / basic (ref)
Secondary 0.71 0.66–0.76 0.71 0.66–0.76 0.70 0.66–0.75
High 0.65 0.55–0.71 0.66 0.60–0.73 0.66 0.60–0.73
Countries
Belgium 0.94 0.54–1.65 0.90 0.48–1.68 1.11 0.33–3.65
Italy 2.61 2.20–3.10 3.16 2.37–4.20 2.35 1.90–2.90
Malta 0.35 0.11–1.11 0.35 0.11–1.11 - -
Portugal 3.61 2.15–6.09 4.28 2.19–8.38 2.89 1.29–6.45
Spain 3.10 2.25–4.28 4.91 3.08–7.82 2.07 1.33–3.23
Data are collected for women aged from 50 to 69 years
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publicizing them to migrants and health care providers,
ensuring appropriate implementation measures, and by
not conditioning health care to a person’s immigration
status [37]. Italy, Spain and Portugal adopted specific na-
tional policies aimed at improving migrant health. Italy
and Spain focussed policies on sexual and reproductive
health care and communicable disease. [38] Portugal in-
troduced measures which included training, education
and communication programmes to inform health pro-
fessionals of the legal rights of migrants, plus the
promotion of partnerships to improve the quality of ser-
vices provided and facilitate change in organizational
culture. [39] Malta adopted public health policy target-
ing the most vulnerable groups in general, first for
screening programmes and vaccination. [25] In contrast,
in Belgium there is not yet a clear political commitment
to tackling either health inequalities or ethnic inequal-
ities in health, although there is a growing interest re-
garding this issue. [40] Lack of targeted policies may
explain the large gap between nationals and non-EU
Table 8 Odds Ratio of not reporting a Pap smear test in the past 3 years
Migrants EU Migrants Non-EU Migrants
OR CI 95% OR CI 95% OR CI 95%
Migrant status
National (ref)
Migrant status 1.70 1.59–1.82 1.53 1.36–1.71 1.80 1.65–1.96
Educational level
No education / basic (ref)
Secondary 0.63 0.60–0.66 0.63 0.60–0.66 0.64 0.61–0.67
Higher 0.55 0.52–0.59 0.56 0.53–0.60 0.57 0.53–0.60
Countries
Belgium 1.42 1.08–1.86 1.09 0.79–1.52 2.46 1.56–3.88
Italy 1.95 1.79–2.13 1.71 1.48–1.97 2.10 1.89–2.34
Malta 0.83 0.43–1.59 0.58 0.24–1.43 1.29 0.50–3.33
Portugal 1.43 1.07–1.91 2.13 1.36–3.36 1.11 0.77–1.61
Spain 1.40 1.20–1.64 1.73 1.32–2.27 1.28 1.07–1.54
Data are collected for women between 20 and 69 years
Table 9 Odds Ratio of not reporting a colorectal cancer screening in the past 2 years
Migrants EU Migrants Non-EU Migrants
OR CI 95% OR CI 95% OR CI 95%
Migrant status
National (ref)
Migrant status 1.57 1.33–1.86 1.20 0.95–1.52 1.97 1.55–2.50
Educational level
No education / basic (ref) 1.00 1.00 1.00
Secondary 0.90 0.84–0.95 0.90 0.85–0.96 0.89 0.84–0.95
Higher 0.82 0.76–0.90 0.84 0.77–0.90 0.82 0.76–0.90
Gender
Men (ref)
Women 1.11 1.05–1.17 1.11 1.06–1.17 1.11 1.05–1.17
Estimates by country
Belgium 0.88 0.59–1.32 0.75 0.49–1.15 2.11 0.64–6.95
Italy 1.99 1.56–2.53 1.71 1.15–2.53 2.15 1.59–2.91
Malta 0.14 0.05–0.41 0.18 0.05–0.56 0.02 0.00–0.37
Portugal 1.70 1.09–2.67 1.76 1.00–3.10 1.62 0.78–3.36
Spain 1.13 0.70–1.81 2.49 0.92–6.78 0.76 0.44–1.31
Data are collected for men and women aged between 50 and 74 years
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migrants in accessing female screening and colorectal
screening in Belgium, as well as the lack of training of
health care professionals. Such a gap is high in Italy as
well, notwithstanding the presence of targeted policies,
both for EU migrants and non-EU migrant. This can be
due to enduring problems in the organization of health
services, [41] that may affect more vulnerable groups,
who have limited means to overcome the barriers cre-
ated by poor organization of health services.
In our study, we also considered two important risk fac-
tors of inequality in the uptake of vaccination and screen-
ing, namely disability and education levels. Disability did
not seem to play a role when comparing access to PHSs
between migrants and nationals, in contrast to education
levels, especially for mammography, Pap smear tests
and flu vaccination. Knowledge of differences in
health, social and economic conditions is essential for
providing equal access to preventive care.
This study was limited by the fact that information on
length of stay and area of origin was not considered in
detail. In particular, length of stay may play a role in
view of the evidence that migrants with a shorter length
of stay record lower rates of access/use of health care
services, including PHSs [14, 42]. The overall results
must be cautiously interpreted because migrant popula-
tions in different countries differ in many ways, espe-
cially on the rules for acquiring citizenship and
migrants’ rights with regard to health care access. This
means that conclusions drawn from comparing coun-
tries may be more tentative than indicative. Finally, the
study only included documented migrants: asylum
seekers and refugees are not included in HISs and there-
fore were not considered in the study.
Many factors may contribute to hindering migrants’ ac-
cess to PHSs, such as length of stay in host country, reli-
gion and levels of literacy. However, using the information
available in HISs, only some factors can be investigated, in
particular education, gender and the presence of disability.
The major strength of the study is its national repre-
sentativeness and the excellent comparability of the data
among countries, ensured by the harmonisation of data
sources at EU level.
Conclusions
The study provided information about the extent of the
gap in accessing PHSs between nationals and migrants in
five EU countries. Italy presented the highest gap, while
Belgium showed higher risks for non-EU migrants. Poor
organization of health services, in Italy, and lack of tar-
geted health policies may explain the findings. In general,
only a few prevention programmes exclusively target mi-
grant groups [43]. PHSs should be responsive to patient
diversity, probably more than other health services. There
is a need for diversity-oriented, migrant-sensitive preven-
tion and a need for prevention programs addressing mi-
grants that are large-scale, evidence-based, sustainable
and regularly evaluated. Policies oriented to removing im-
pediments to migrants’ access to preventive interventions
are crucial, in order to encourage more positive actions
for those facing the risk of intersectional discrimination.
Table 10 Odds Ratio of not a reporting a vaccination against flu in the past 12 months
Migrants EU Migrants Non-EU Migrants
OR CI 95% OR CI 95% OR CI 95%
Migrant status
National (ref)
Migrant status 3.69 3.24–4.21 2.85 2.32–3.49 4.42 3.72–5.25
Educational level
No education / basic (ref)
Secondary 0.65 0.61–0.69 0.65 0.62–0.69 0.65 0.62–0.69
Higher 0.65 0.61–0.70 0.65 0.61–0.70 0.65 0.61–0.70
Gender
Men (ref)
Women 0.88 0.85–0.92 0.89 0.86–0.92 0.89 0.86–0.92
Estimates by country
Belgium 1.62 1.03–2.55 1.86 1.11–3.13 1.03 0.422.51
Italy 4.63 3.94–5.45 4.18 3.08–5.67 4.82 3.98–5.82
Malta 0.80 0.29–2.21 0.80 0.29–2.21
Portugal 2.43 1.27–4.65 2.19 1.14–4.24
Spain 1.56 1.05–2.31 1.45 0.85–2.46 1.71 0.96–3.04
Data are collected for men and women aged of 65 years and over
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Table 11 Description of preventive health services provided in the five European countries surveyed
Organized screening program Year of implementation
of the screening program
Inclusion of the screening as item
of the Health Interview Survey
Screening test
Mammography
Belgium Yes 2001 Yes
Italy Yes 1990 Yes
Malta Yes 2009 Yes
Portugal Yes 1990 No
Spain Yes 1990 Yes
Pap smear test
Belgium Yes (only Flanders) 2013 Yes
Italy Yes 1996 Yes
Malta Yes 2016 Yes
Portugal Yes 1990 No
Spain Yes 1986 Yes
Colorectal screening
Belgium Yes 2009 No
Italy Yes 2005 Yes
Malta Yes 2013 No
Portugal Yes 2009 No
Spain Yes 2000 Yes
The table contains information about the presence of organized screening program, separately for mammography, Pap smear test and colorectal
screening; the year of implementation of the screening program and the inclusion of information about the screenings as an item of the Health
Interview Survey in the five studied countries
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